Literature DB >> 35227550

Italian guidelines for the treatment of type 2 diabetes.

Edoardo Mannucci1, Riccardo Candido2, Lina Delle Monache3, Marco Gallo4, Andrea Giaccari5, Maria Luisa Masini6, Angela Mazzone7, Gerardo Medea8, Basilio Pintaudi9, Giovanni Targher10, Marina Trento11, Giuseppe Turchetti12, Valentina Lorenzoni12, Matteo Monami13.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35227550     DOI： 10.1016/j.numecd.2022.01.027

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN： 0939-4753            Impact factor:   4.222


× No keyword cloud information.
  1 in total

Review 1.  A Health Technology Assessment Based on Chinese Guidelines: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Type 2 Diabetes Complicated with Cardiovascular Disease.

Authors:  Zeyu Xie; Jinjian Li; Sensen Yang; Weishang Deng; Jisheng Chen
Journal:  Ther Clin Risk Manag       Date:  2022-08-30       Impact factor: 2.755
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.